Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Hisamitsu Pharmaceutical Co ( (JP:4530) ) has issued an announcement.
Hisamitsu Pharmaceutical Co., Inc. announced the acquisition of 1,765,400 of its own shares for approximately 7.1 billion yen as part of a strategy to enhance shareholder returns. This move aligns with their Basic Policy on Cash Allocation, aiming to return over 50 billion yen to shareholders through dividends and buybacks by 2031, reflecting the company’s commitment to sustainable value and financial stability.
More about Hisamitsu Pharmaceutical Co
Hisamitsu Pharmaceutical Co., Inc. is a company based in Tosu, Saga, primarily operating in the pharmaceutical industry. It is known for producing medical products, including transdermal patches, and focuses on enhancing shareholder value and sustainable growth.
Average Trading Volume: 154,357
Technical Sentiment Signal: Sell
Current Market Cap: Yen292.2B
Find detailed analytics on 4530 stock on TipRanks’ Stock Analysis page.